Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Sylvie Bonvalot"'
Autor:
Levy A; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Bonvalot S; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Callegaro D; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Botticella A; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Le Cesne A; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Gronchi A; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France., Le Péchoux C; Antonin Levy, Gustave Roussy Cancer Campus; INSERM U1030, Molecular Radiotherapy, Villejuif, France; Sylvie Bonvalot, Institut Curie; PSL Research University, Paris, France; Dario Callegaro, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Angela Botticella, Axel Le Cesne, Gustave Roussy Cancer Campus Villejuif, France; Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; and Cécile Le Péchoux, Gustave Roussy Cancer Campus Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Aug 01; Vol. 36 (22), pp. 2357-2358. Date of Electronic Publication: 2018 Jun 07.
Autor:
Rodrigo RS; Medicine Department, Institut Gustave Roussy, Villejuif, France., Nathalie A, Elodie T, Gonzalo GA, Philippe T, Françoise D, Julien D, Angela C, Bérénice B, Jean-Yves B, Jean-Michel C, Jean B, Sylvie B, Axel le C
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2011 Jun; Vol. 47 (9), pp. 1319-27. Date of Electronic Publication: 2011 Mar 28.
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1348 (2022)
Uterine sarcomas are rare, aggressive tumors with poor prognosis that can be further negatively affected by inadequate surgical approaches such as morcellation. There are no clinical and radiologic criteria for differentiating leiomyoma from malignan
Externí odkaz:
https://doaj.org/article/7137a081c1c442c185027f59b810b197
Autor:
Elodie Gaignard, Dimitri Tzanis, Toufik Bouhadiba, David C. Kieser, Fabien Robin, Damien Bergeat, Bernard Meunier, Sylvie Bonvalot
Publikováno v:
BMC Surgery, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Monobloc resection of soft tissue sarcomas (STSs) has a major impact on overall survival and local recurrence. Anatomical boundaries, such as the sciatic notch, increase the risk of fragmentation of the lesion. To date there are f
Externí odkaz:
https://doaj.org/article/c6bce3ed569541a990a4921ad94a1520
Publikováno v:
Annals of Surgical Oncology. 29:7297-7311
Primary localized retroperitoneal soft tissue sarcomas (RPS) have shorter survival than other soft tissue sarcoma sites owing to higher local recurrence rates associated with histologic types most commonly found in this location, large tumor size at
Autor:
Frits van Coevorden, Francesco Barretta, Rebecca A. Gladdy, Carol Jane Swallow, Dario Callegaro, Charles Honoré, Yvonne Schrage, Winan J. van Houdt, Eberhard Stoeckle, Dirk C. Strauss, Mark Fairweather, Deanna Ng, Chandrajit P. Raut, Rosalba Miceli, Rick L. Haas, Nikolaos Vassos, Lorenzo Conti, Piotr Rutkowski, Alessandro Gronchi, Sylvie Bonvalot
Publikováno v:
European Journal of Cancer. 157:291-300
Purpose The aim of this study was to create and validate dynamic nomograms to predict overall survival (OS) and disease-free survival (DFS) at different time points during follow-up in patients who had undergone resection of primary retroperitoneal s
Autor:
Felix Shumelinsky, Clémentine Demaire, Stefano Radaelli, Robert E. Turcotte, Marco Rastrelli, Javier Martin Broto, Georgi Nalbantov, D Strens, Sylvie Bonvalot, Alessandro Gronchi, Lars H. Lindner, Piotr Rutkowski, Antonio Cubillo, Jay S. Wunder, Zsuzsanna Papai
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background] Locally advanced soft tissue sarcoma (STS) management may include neoadjuvant or adjuvant treatment by radiotherapy (RT), chemotherapy (CT) or chemoradiotherapy (CRT) followed by wide surgical excision. While pathological complete respon
Autor:
Jeremy, Smadja, Sophie El, Zein, Gaelle, Pierron, Sarah, Watson, Enora, Laas, Toulsie, Ramtohul, Dimitri, Tzanis, Vincent, Servois, Sylvie, Bonvalot
Publikováno v:
Annals of Surgical Oncology. 30:956-957
Autor:
Silvia Stacchiotti, Anna Maria Frezza, George D. Demetri, Jean-Yves Blay, Jyoti Bajpai, Giacomo G. Baldi, Elizabeth H. Baldini, Robert S. Benjamin, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, Sandra P. D'Angelo, Elizabeth J. Davis, Angelo P. Dei Tos, Elizabeth G. Demicco, Jayesh Desai, Palma Dileo, Mikael Eriksson, Hans Gelderblom, Suzanne George, Rebecca A. Gladdy, Mrinal M. Gounder, Abha A. Gupta, Rick Haas, Andrea Hayes, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugenie S. Kleinerman, Axel Le Cesne, Roberta Maestro, Javier Martin Broto, Robert G. Maki, Aisha B. Miah, Emanuela Palmerini, Shreaskumar R. Patel, Chandrajit P. Raut, Albiruni R.A. Razak, Damon R. Reed, Piotr Rutkowski, Roberta G. Sanfilippo, Marta Sbaraglia, Inga-Marie Schaefer, Dirk C. Strauss, Sandra J. Strauss, William D. Tap, David M. Thomas, Annalisa Trama, Jonathan C. Trent, Winette T.A. van der Graaf, Winan J. van Houdt, Margaret von Mehren, Breelyn A. Wilky, Christopher D.M. Fletcher, Alessandro Gronchi, Rosalba Miceli, Andrew J. Wagner
Publikováno v:
Cancer Treatment Reviews, 110. ELSEVIER SCI LTD
Background: In ultra-rare sarcomas (URS) the conduction of prospective, randomized trials is challenging. Data from retrospective observational studies (ROS) may represent the best evidence available. ROS implicit limitations led to poor acceptance b
Autor:
John E. Mullinax, Mark Fairweather, Rebecca A. Gladdy, David E. Gyorki, Eberhard Stoeckle, Deanna Ng, Carol J. Swallow, Andrew J. Hayes, Robin L. Jones, Ricardo J. Gonzalez, Dirk C. Strauss, Winan J. van Houdt, Samuel J Ford, Chandrajit P. Raut, Dario Callegaro, Marco Fiore, Markus Albertsmeier, Hayden Snow, Piotr Rutkowski, Carolyn Nessim, Kenneth Cardona, Silvia Stacchiotti, D Tzanis, Thomas F. DeLaney, Sylvie Bonvalot, Jacek Skoczylas, Myles Smith, T Bouhadiba, Jae Berm Park, Alessandro Gronchi, Christina L. Roland, Anant Desai, Rick L. Haas
Publikováno v:
Ann Surg Oncol
BACKGROUND. Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015, the Transatlantic Australasian RPS Working Group (TARPSWG) published